The emerging therapy of this peptide represents a significant development in the handling of the condition. Different to existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide061117.targetblogs.com/42323483/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment